Skip to content

Biocom CRO

  • CRO Directory
  • Resources
  • News
  • Blog
  • Events
  • About
  • Contact
  • Close
Contact

CRO Directory

  • All
  • Research
  • Drug Discovery
  • Preclinical Development
  • CMC & Manufacturing
  • Investigational New Drug
  • Phase 1 Clinical Trials
  • Phase 2 Clinical Trials
  • Phase 3 Clinical Trials
  • New Drug Application
  • Phase 4 Clinical Trials & Post-Approval

Month: June 2019

June 10, 2019

Long & Short of USP Guidelines for EL Testing by Avomeen

Sources of Impurities in Pharmaceutical Products In the development of a drug product, careful consideration needs to be given to impurities that may originate from manufacturing equipment, process components, and packaging materials. The majority of such impurities are common chemical additives used to improve the physicochemical properties of a wide range of plastic materials. Suppliers […]

Read More
Posted in blog

Recent Posts

  • CILCARE acquires ISO 9001:2015 certification, demonstrating its commitment to quality and customer excellence
  • Expansion of US Facility: Increased Capacity & Testing Capabilities
  • CRO & CMO List Opportunity for San Diego Business Journal – No Cost to Participate!
  • HPR: On-site MRI services available
  • More Than 100 Companies Adopt eClinical Solutions’ elluminate® Clinical Data Platform to Increase Clinical Trial Efficiency
  • Developing Solutions for Rare Diseases

Archives

  • November 2021
  • August 2021
  • July 2021
  • March 2021
  • February 2021
  • Research
  • Drug Discovery
  • Preclinical
    Development
  • CMC &
    Manufacturing
  • Investigational
    New Drug
  • Phase 1
    Clinical Trials
  • Phase 2
    Clinical Trials
  • Phase 3
    Clinical Trials
  • New Drug
    Application
  • Phase 4 Clinical Trials &
    Post-Approval
Biocom CRO 10996 Torreyana Rd., Suite 200
San Diego, CA 92121
| Office: 858-455-0300 | Fax: 858-455-0022
  • Biocom
  • Privacy Policy
  • Disclaimer
  • Contact